miR-20a Overexpression in Adipose-Derived Mesenchymal Stem Cells Promotes Therapeutic Efficacy in Murine Lupus Nephritis by Regulating Autophagy

miR-20a Overexpression in Adipose-Derived Mesenchymal Stem Cells Promotes Therapeutic Efficacy in Murine Lupus Nephritis by Regulating Autophagy

Objective. Lupus nephritis is the most common and severe complication of systemic lupus erythematosus. The aim of our study was to investigate the efficacy of miR-20a overexpressing adipose-derived stem cell (ADSC) transplantation in murine lupus nephritis (LN) and explore potential molecular mechan...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shanshan Wei, Zhiwen Zhang, Lu Yan, Yinjuan Mo, Xianwen Qiu, Xiangbin Mi, Kuan Lai
Format:	Article
Language:	English
Published:	Wiley 2021-01-01
Series:	Stem Cells International
Online Access:	http://dx.doi.org/10.1155/2021/3746335
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Autophagy in patients with lupus nephritis and its effect on podocyte related protein expression
by: LI Zhang-hong, et al.
Published: (2020-01-01)

Anti-OSM Antibody Inhibits Tubulointerstitial Lesion in a Murine Model of Lupus Nephritis
by: Qingjuan Liu, et al.
Published: (2017-01-01)

Identification and validation of key autophagy-related genes in lupus nephritis by bioinformatics and machine learning.
by: Su Zhang, et al.
Published: (2025-01-01)

Inhibition of VEGFR-3 by SAR131675 decreases renal inflammation and lymphangiogenesis in the murine lupus nephritis model
by: Tian Wang, et al.
Published: (2025-07-01)

The Evolution of Crescents in Lupus Nephritis
by: Ana Malvar, et al.
Published: (2025-05-01)

Dysregulation of miR-155-5p and miR-200-3p and the Anti-Non-Bilayer Phospholipid Arrangement Antibodies Favor the Development of Lupus in Three Novel Murine Lupus Models
by: Luz Ángela Zárate-Neira, et al.
Published: (2017-01-01)

WCN24-1455 NOT EVERYTHING IN LUPUS IS LUPUS NEPHRITIS
by: Enrique Fleuvier Morales López, et al.
Published: (2024-04-01)

Gender Differences in the Pathogenesis and Outcome of Lupus and of Lupus Nephritis
by: Julie Schwartzman-Morris, et al.
Published: (2012-01-01)

The diagnostic and predictive potential of lncRNA CASC2 targeting miR-155 in systemic lupus erythematosus patients with nephritis complication
by: Nada R. Mohamed, et al.
Published: (2024-12-01)

Prospects for the use of belimumab in lupus nephritis
by: N. L. Kozlovskaya, et al.
Published: (2021-08-01)

Evaluation of Treatment Response in Lupus Nephritis
by: Anca BOBIRCA, et al.
Published: (2021-12-01)

Recent advances in the treatment of lupus nephritis
by: Wan-xing Li, et al.
Published: (2022-08-01)

USE OF RITUXIMAB IN PATIENTS WITH LUPUS NEPHRITIS
by: Anna Vasilyevna Torgashina, et al.
Published: (2010-08-01)

Clinical application of belimumab in lupus nephritis
by: Zhou Han, et al.
Published: (2022-10-01)

The impacts of gender differences on systemic lupus erythematosus and lupus nephritis
by: LI Chun-hong, et al.
Published: (2019-01-01)

Circulating plasma derived exosomes from systemic lupus erythematosus aggravate lupus nephritis through miR-122-5p/FOXO3-mediated macrophage activation
by: Juan Ji, et al.
Published: (2024-12-01)

miR-6516-3p-mediated downregulation of the endogenous MMP-9 inhibitor RECK in mesangial cells might exacerbate lupus nephritis
by: Hiroyuki Tomita, et al.
Published: (2025-03-01)

Spatial transcriptomics reveals regional characteristics of lupus nephritis in murine kidneys and immune response to prednisolone or Gancao Nourishing‐Yin decoction therapies
by: Yanjuan Chen, et al.
Published: (2025-02-01)

Immune Checkpoint Therapy–Induced Lupus Nephritis
by: Imran Humza Hanif, et al.
Published: (2024-05-01)

Lupus nephritis: What new is in morphological diagnosis?
by: S G Radenska-Lopovok
Published: (2008-08-01)

Lupus Nephritis: 10 questions to think about
by: Enrique Morales, et al.
Published: (2025-02-01)

Chemokines and Chemokine Receptors in the Development of Lupus Nephritis
by: Xiaofeng Liao, et al.
Published: (2016-01-01)

Lupus nephritis and thrombotic microangiopathy: A review
by: Larisa A. Bobrova, et al.
Published: (2024-01-01)

Prediction of prognosis and renal outcome in lupus nephritis
by: Farah Tamirou, et al.
Published: (2020-10-01)

Disseminated Strongyloidiasis in a Patient With Lupus Nephritis
by: Muhammad Abu-Rmaileh, et al.
Published: (2023-09-01)

MicroRNAs Implicated in the Immunopathogenesis of Lupus Nephritis
by: Cristen B. Chafin, et al.
Published: (2013-01-01)

Renal biopsy in lupus nephritis: To do or not to do?
by: Manish Rathi, et al.
Published: (2017-01-01)

Clinical significance of urine hepcidin in lupus nephritis
by: TANG Dai-rong, et al.
Published: (2017-01-01)

B cells and treatment progression in lupus nephritis
by: ZHANG Yue-qi, et al.
Published: (2019-01-01)

Research advances of the role of T lymphocytes in lupus nephritis
by: Zhang Ling-ge, et al.
Published: (2022-03-01)

Ras-MAPK pathway in patients with lupus nephritis
by: Dandan Liang, et al.
Published: (2025-03-01)

Murine Nephrotoxic Nephritis as a Model of Chronic Kidney Disease
by: M. K. E. Ougaard, et al.
Published: (2018-01-01)

Lupus nephritis as a specific clinical and immunological phenotype of systemic lupus erythematosus
by: E. A. Aseeva, et al.
Published: (2022-12-01)

Lupus Nephritis in a Patient with Sickle Cell Disease
by: Vinay Minocha, et al.
Published: (2013-01-01)

Soluble Fas and the −670 Polymorphism of Fas in Lupus Nephritis
by: Juan José Bollain-y-Goytia, et al.
Published: (2014-01-01)

Correlation between dyslipidemia and disease activity of lupus nephritis
by: Hu Hong-tu, et al.
Published: (2021-01-01)

FDA approves belimumab for treatment of children with lupus nephritis
by: article Editorial
Published: (2022-10-01)

TNIP1/ABIN1 and lupus nephritis: review
by: Makayla P Brady, et al.
Published: (2020-10-01)

Cyclophosphamide and mycophenolate mofetil as induction therapy in lupus nephritis
by: Božić-Majstorović Ljubinka, et al.
Published: (2024-01-01)

Determination of nutrition index and correlation with activity of lupus nephritis
by: Rabrenović Violeta, et al.
Published: (2024-01-01)